US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

Pharmaceuticals: market research reports

The pharmaceutical industry is a $1 trillion-dollar sector and has been a major engine of economic growth and scientific advancement for decades. The industry encompasses a wide range of enterprises including large ethical drug multi-nationals (so-called Big Pharma), mid-sized specialty pharmaceutical companies, generic manufacturers, virtual pharmas, small biotechnology and biopharmaceutical firms, and all the various ancillary support and service companies that provide contract research, regulatory guidance, contract sales, and manufacturing technologies and raw materials.

Although growth has not been as robust in recent years—mainly due to price pressures, uncertainty in regulatory/reform measures, and weak drug pipelines— the demographic and structural drivers of demand in healthcare still exist: namely, the continued aging of the global population and the increasing sophistication and wealth of developing nations. Shifting epidemiology patterns and outbreaks, along with new challenges in chronic disease, cancer, heart disease, and degenerative disease will continue to impel the need for ever-better medicines. New understanding and technologies in drug delivery, and most especially in the fields of genomics, proteomics, and molecular biology generally, also hold promise for better therapeutics and a revival of profits.

  • Biopharmaceuticals (255)
  • Diseases & Conditions (3954)
  • Drug Delivery (279)
  • Therapeutic Area (7137)
  • Vaccines (720)
RSS Feeds

Pharmaceuticals market research reports and industry analysis

< prev 1    3  4  5  6  7  8  9  10  
Kinase Inhibitors for Treating Cancer: Industry Analysis, R&D Trends and World Market Forecasts 2014-2024
9/6/2014 | published by: Visiongain
... of kinase inhibitors? Now get the latest analysis for those cancer treatments. There you explore developments, other trends, results, opportunities and revenue forecasts. Visiongain’s new report shows you what’s possible for drugs using protein kinase ...  |  read more...
USD 2,986
PHARMACEUTICAL MARKET INDIA 2014-2020 : Formulations, Active Pharmaceutical Ingredients (APIs), Contract Research and Manufacturing Services (CRAMS), Biosimilars, Generics & Vaccines
8/1/2014 | published by: Kelly Scientific Publications
... Biosimilars, Generics & Vaccines” by Kelly Scientific Publications is a comprehensive report on the pharmaceutical and biotechnology industry in India and its impact on international markets. This report scrutinises top Indian pharmacos and their battle ...  |  read more...
USD 2,000
Latest Guidebook for Conducting Pharma Clinical Trials - China: From Regulations to Practice (2014 Edition)
7/25/2014 | published by: Access China Management Consulting Ltd.
... of the largest healthcare markets around the world. Along with sustained economic and population growth as well as an ageing population, Chinese healthcare market has maintained annually average growth rate above 16 % since 1990s. ...  |  read more...
USD 1,495
Pharmaceuticals and Healthcare Report - Malaysia - Q3 2014
7/23/2014 | published by: Business Monitor International
... However, wehave downgraded Malaysia's pharmaceutical sales forecast due to a slowdown in pharmaceutical trade in2013. The country's slower economic growth in 2014, coupled with the fact that investment in thepharmaceuticals sector will take longer than ...  |  read more...
USD 1,295
Pharmaceuticals and Healthcare Report - Sri Lanka - Q3 2014
7/23/2014 | published by: Business Monitor International
... and the government focused onimproving the domestic pharmaceutical sector. We therefore expect that pharmaceutical and healthcaresector growth will outpace economic growth over the five-year forecast period. Improved relations withIndia, after the country abstained from voting ...  |  read more...
USD 1,295
Pharmaceuticals and Healthcare Report - Czech Republic - Q3 2014
7/23/2014 | published by: Business Monitor International
... the healthcare system willcontinue to impact demand within the Czech Republic. We also believe the new centre-left coalitiongovernment poses downside risk to our forecasts given its commitment to containing healthcare costs andimproving access to medicines. ...  |  read more...
USD 1,295
Pharmaceuticals and Healthcare Report - Denmark - Q3 2014
7/23/2014 | published by: Business Monitor International
... for its wellestablished,albeit relatively small, pharmaceutical market. The robust demand for healthcare services willsee the Danish government continue to adapt strategies and cost-containment measures to manageincreasing healthcare costs. Despite this, we believe the country's high ...  |  read more...
USD 1,295
Pharmaceuticals and Healthcare Report - United Arab Emirates - Q3 2014
7/23/2014 | published by: Business Monitor International
... aiming to introduce comprehensive health insurance throughoutthe country, allowing businesses to shoulder much of the cost of this expanded coverage, the governmentwill gradually contribute less to the country's healthcare spending. Between 2013 and 2018, we ...  |  read more...
USD 1,295
Pharmaceuticals and Healthcare Report - Iraq - Q3 2014
7/23/2014 | published by: Business Monitor International
... expansions in 2014, and the Ministry of Health recently awarded 18 health project contractsworth USD276mn. In addition, new restrictions aim to end the chaos in which materials have entered thecountry in previous years, targeting control ...  |  read more...
USD 1,295
Pharmaceuticals and Healthcare Report - Kuwait - Q3 2014
7/23/2014 | published by: Business Monitor International
... is likely tohave a significant impact on margins in the sector, implementation remains slow. Concern over fakegeneric drugs presents opportunities for the segment in the country, and has spurred partnershipagreements with local distributors in the ...  |  read more...
USD 1,295
Pharmaceuticals and Healthcare Report - Portugal - Q3 2014
7/23/2014 | published by: Business Monitor International
... to growth in 2015, while pharmaceuticals will not return to growth until 2019. This isbecause while Portugal exited its bailout programme in May 2014 without the need for a new financialpackage, government austerity measures are ...  |  read more...
USD 1,295
Pharmaceuticals and Healthcare Report - Qatar - Q3 2014
7/23/2014 | published by: Business Monitor International
... by the membercountries of the Gulf Co-operation Council (GCC). The unified regional pharmaceutical pricingpolicy among GCC member states will reduce medicine prices in Qatar and improve its national drugaccessibility, if implemented properly. Although the drug ...  |  read more...
USD 1,295
Pharmaceuticals and Healthcare Report - South Africa - Q3 2014
7/23/2014 | published by: Business Monitor International
... and poised for high single-digitgrowth over the next decade. Headline Expenditure Projections Pharmaceuticals: ZAR34.01bn (USD3.52bn) in 2013 to ZAR37.53bn (USD3.51bn) in 2014; +10.3% inlocal currency terms and -0.5% in US dollar terms. Forecast broadly in ...  |  read more...
USD 1,295
Global Parkinson's Disease Market : 2014-2018
7/23/2014 | published by: TechNavio - Infiniti Research Ltd.
... GlaxoSmithKline plc, Novartis AG and Teva Pharmaceutical Industries Ltd. Other prominent vendors in this market are: Abbvie Inc., Akorn Inc., Astellas Pharma Inc., Desitin Arzneimittel GmbH, Endo International plc, F. Hoffmann-La Roche Ltd., H. Lundbeck ...  |  read more...
USD 2,500
Health Supplement Stores
7/21/2014 | published by: First Research, Inc.
... based in the US). Worldwide, vitamins and dietary supplements generate about $85 billion in annual sales from all channels, according to Euromonitor. The US is the world's largest market and China is the fastest-growing. Growth ...  |  read more...
USD 129
Kidney Dialysis Centers
7/21/2014 | published by: First Research, Inc.
... Braun Melsungen. The US commercial kidney dialysis industry includes about 4,200 centers with combined annual revenue of about $16 billion. COMPETITIVE LANDSCAPE Demand depends on the number of people who suffer from kidney disease. The ...  |  read more...
USD 129
Pharmaceuticals and Healthcare Report Q3 2014 - Moldova
7/16/2014 | published by: Business Monitor International
... with the EU inJune 2014, which would strengthen the business environment and improve the regulatory structure andaccess to the pharmaceutical market in the country. Moldova is undertaking a reform of its healthcaresector with the World ...  |  read more...
USD 1,295
Pharmaceuticals and Healthcare Report Q3 2014 - Spain
7/16/2014 | published by: Business Monitor International
... to drugmakers operating in the country. Despite calls made by companies for theimplementation of a system that adequately rewards innovation and supports investment in futuremedicines, the government is likely to remain committed to fiscal consolidation ...  |  read more...
USD 1,295
Pharmaceuticals and Healthcare Report Q3 2014 - Ghana
7/16/2014 | published by: Business Monitor International
... remain positive for the sectorwith the government's focus on domestic pharmaceutical sector, greater foreign pharmaceutical companyinterest in the country and capacity building initiatives for bringing global quality control standards toGhanaian pharmaceutical industry will spur domestic ...  |  read more...
USD 1,295
Advancement in Liquid Dosage Excipients (Parenteral & Transdermal)
7/16/2014 | published by: Frost & Sullivan
... the year 2018 with a CAGR of ??%. The total global parenteral finished products market is estimated to be worth $??billion. Parenteral finished products include vials with sterile liquids or powders to be reconstituted for ...  |  read more...
USD 3,000
Pharmaceuticals and Healthcare Report Q3 2014 - Greece
7/16/2014 | published by: Business Monitor International
... will continue to target the pharmaceutical and healthcare industry to reduce public spending.We highlight, however, that the generic drug sector and private healthcare industry will present somegrowth opportunities in the country. Headline Expenditure Projections Pharmaceuticals: ...  |  read more...
USD 1,295
Pharmaceuticals and Healthcare Report Q3 2014 - Lithuania
7/16/2014 | published by: Business Monitor International
... The upcoming switch to theeuro promises to boost purchasing power and stabilise the pharmaceutical market, albeit at the cost ofincreasing healthcare expenditure. Ceding control of monetary policy to Brussels leaves Lithuania withlittle leeway to increase ...  |  read more...
USD 1,295
Pharmaceuticals and Healthcare Report Q3 2014 - Serbia
7/16/2014 | published by: Business Monitor International
... reduce itsdebt burden. However, pharmaceutical spending is also a target for cuts. Local drug makers are set to feelthe worst of these new measures as they cannot compete on cost compared to larger players in ...  |  read more...
USD 1,295
Pharmaceuticals and Healthcare Report Q3 2014 - Slovakia
7/16/2014 | published by: Business Monitor International
... agencyTASR. The government added that after adding contributions from the state budget, the total funds that havebeen allocated for developing healthcare infrastructure will be EUR300mn (USD417.3mn). The governmentplans to allocate these funds to projects in ...  |  read more...
USD 1,295
EUSA Pharma, Inc. : Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
7/15/2014 | published by: MarketLine
... organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' EUSA Pharma, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports ...  |  read more...
USD 350
< prev 1    3  4  5  6  7  8  9  10